Skip to main content
. 2024 Mar 12;16(3):387. doi: 10.3390/pharmaceutics16030387
Analyte Q1
(m/z)
Q3
(m/z)
CE
(eV)
4-HPR 392.3 283.3 16
4-oxo-4-HPR 406.2 297.1 16
4-MPR 406.3 283.2 16
DH-4-HPR 390.2 281.1 16
[2H4]-4-HPR 396.3 283.2 18